Cargando…

Dendritic Cell-Based Immunotherapy in Hot and Cold Tumors

Dendritic cells mediate innate and adaptive immune responses and are directly involved in the activation of cytotoxic T lymphocytes that kill tumor cells. Dendritic cell-based cancer immunotherapy has clinical benefits. Dendritic cell subsets are diverse, and tumors can be hot or cold, depending on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Byeong Hoon, Lee, Heung Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9266676/ https://www.ncbi.nlm.nih.gov/pubmed/35806328 http://dx.doi.org/10.3390/ijms23137325

Ejemplares similares

Turning ‘Cold’ tumors ‘Hot’: immunotherapies in sarcoma
por: Rytlewski, Jeff, et al.
Publicado: (2021)

Igniting Hope for Tumor Immunotherapy: Promoting the “Hot and Cold” Tumor Transition
por: Wei, Chen, et al.
Publicado: (2022)

Dendritic Cell-Based Immunotherapy for Solid Tumors()()
por: Jung, Nam-Chul, et al.
Publicado: (2018)

Turning cold tumors into hot tumors by improving T-cell infiltration
por: Liu, Yuan-Tong, et al.
Publicado: (2021)

Chemokines in the Landscape of Cancer Immunotherapy: How They and Their Receptors Can Be Used to Turn Cold Tumors into Hot Ones?
por: Karin, Nathan
Publicado: (2021)

Differential Roles of Lung Dendritic Cell Subsets Against Respiratory Virus Infection
por: Kim, Tae Hoon, et al.
Publicado: (2014)

Hot and cold tumors: Immunological features and the therapeutic strategies
por: Wang, Lianjie, et al.
Publicado: (2023)

The role of dendritic cells in tumor microenvironments and their uses as therapeutic targets
por: Kim, Chae Won, et al.
Publicado: (2021)

Contribution of Dendritic Cells in Protective Immunity against Respiratory Syncytial Virus Infection
por: Jung, Hi Eun, et al.
Publicado: (2020)

Dendritic cell biology and its role in tumor immunotherapy
por: Wang, Yingying, et al.
Publicado: (2020)

Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer
por: Newman, Jenna H., et al.
Publicado: (2020)

Predicting prognosis, immunotherapy and distinguishing cold and hot tumors in clear cell renal cell carcinoma based on anoikis-related lncRNAs
por: Hao, Chao, et al.
Publicado: (2023)

Immunologic Strategies in Pancreatic Cancer: Making Cold Tumors Hot
por: Ullman, Nicholas A., et al.
Publicado: (2022)

Turning “Cold” Into “Hot” Tumors—Opportunities and Challenges for Radio-Immunotherapy Against Primary and Metastatic Brain Cancers
por: Sevenich, Lisa
Publicado: (2019)

Recent Advancements in Nanomedicine for ‘Cold’ Tumor Immunotherapy
por: Chen, Qinjun, et al.
Publicado: (2021)

Dendritic cells loaded with tumor derived exosomes for cancer immunotherapy
por: Liu, Hongyu, et al.
Publicado: (2017)

Dendritic Cell-Based Immunotherapy for Prostate Cancer
por: Jähnisch, Hanka, et al.
Publicado: (2010)

Dendritic Cell-Based Immunotherapies and their Potential use in Colorectal Cancer Immunotherapy
por: Aldahlawi, Alia M., et al.
Publicado: (2021)

Distinct features of dendritic cell-based immunotherapy as cancer vaccines
por: Lee, Chaelin, et al.
Publicado: (2018)

Dendritic Cell-Based Immunotherapy of Acute Myeloid Leukemia
por: Van Acker, Heleen H., et al.
Publicado: (2019)

Recent Progress in Dendritic Cell-Based Cancer Immunotherapy
por: Matsuo, Kazuhiko, et al.
Publicado: (2021)

Leveraging STING, Batf3 Dendritic Cells, CXCR3 Ligands, and Other Components Related to Innate Immunity to Induce A “Hot” Tumor Microenvironment That Is Responsive to Immunotherapy
por: Reschke, Robin, et al.
Publicado: (2022)

Hot and Cold Drinks
Publicado: (1883)

Superconductivity, hot and cold
por: Cyrot, M
Publicado: (1988)

Mast Cells and Dendritic Cells as Cellular Immune Checkpoints in Immunotherapy of Solid Tumors
por: Kalkusova, Katerina, et al.
Publicado: (2022)

Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
por: Dolcetti, Riccardo, et al.
Publicado: (2020)

Hot and Cold Tumors: Is Endoglin (CD105) a Potential Target for Vessel Normalization?
por: Ollauri-Ibáñez, Claudia, et al.
Publicado: (2021)

A Potential Protein Adjuvant Derived from Mycobacterium tuberculosis Rv0652 Enhances Dendritic Cells-Based Tumor Immunotherapy
por: Lee, Seung Jun, et al.
Publicado: (2014)

Reversing cold tumors to hot: An immunoadjuvant-functionalized metal-organic framework for multimodal imaging-guided synergistic photo-immunotherapy
por: Fan, Zhijin, et al.
Publicado: (2020)

Metabolism of Dendritic Cells in Tumor Microenvironment: For Immunotherapy
por: Peng, Xin, et al.
Publicado: (2021)

Plasmacytoid Dendritic Cells and Cancer Immunotherapy
por: Fu, Chunmei, et al.
Publicado: (2022)

Dendritic cell immunotherapy: clinical outcomes
por: Apostolopoulos, Vasso, et al.
Publicado: (2014)

Targeting resistance to radiation-immunotherapy in cold HNSCCs by modulating the Treg-dendritic cell axis
por: Knitz, Michael W, et al.
Publicado: (2021)

Dendritic Cell-Based Immunotherapy Treatment for Glioblastoma Multiforme
por: Yang, Liu, et al.
Publicado: (2015)

Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic
por: Hoang, My-Dung, et al.
Publicado: (2015)

Trial watch: Dendritic cell (DC)-based immunotherapy for cancer
por: Laureano, Raquel S, et al.
Publicado: (2022)

The hot ‘n’ cold of cue-induced drug relapse
por: Pitchers, Kyle K., et al.
Publicado: (2018)

Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy
por: Hernández, Sabina Sánchez, et al.
Publicado: (2022)

A Hot Topic: Cancer Immunotherapy and Natural Killer Cells
por: Michel, Tatiana, et al.
Publicado: (2022)

Inhibition of Vps34 reprograms cold into hot inflamed tumors and improves anti–PD-1/PD-L1 immunotherapy
por: Noman, Muhammad Zaeem, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_k0nf9s7jed01qj22f99pkb2ilm